SIEMENS HEALTH ADR/050 (F:SHL1) — Stock Price
SIEMENS HEALTH ADR/050 (F:SHL1) is currently trading at €17.80 EUR, down 4.81% today. Over the past 52 weeks, shares have ranged between €17.40 and €24.80. This page tracks SIEMENS HEALTH ADR/050's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is SIEMENS HEALTH ADR/050 worth.
SIEMENS HEALTH ADR/050 (SHL1) Stock Price Chart — Daily History & Trading Volume
The chart below tracks SIEMENS HEALTH ADR/050's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
SIEMENS HEALTH ADR/050 Income Statement — Revenue, Profit & Earnings by Year
SIEMENS HEALTH ADR/050's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Revenue | €22.36 Billion | €21.68 Billion | €21.71 Billion |
| Cost of Revenue | €13.89 Billion | €13.97 Billion | €13.58 Billion |
| Gross Profit | €8.47 Billion | €7.71 Billion | €8.14 Billion |
| Research & Development | €1.92 Billion | €1.87 Billion | €1.78 Billion |
| SG&A | €3.68 Billion | €3.61 Billion | €3.41 Billion |
| Total Operating Expenses | €19.55 Billion | €19.55 Billion | €18.79 Billion |
| Operating Income | €2.81 Billion | €2.13 Billion | €2.92 Billion |
| EBITDA | — | — | — |
| EBIT | — | — | — |
| Interest Expense | €476.00 Million | €296.00 Million | €118.00 Million |
| Income Before Tax | €2.52 Billion | €1.93 Billion | €2.80 Billion |
| Income Tax Expense | — | — | — |
| Net Income | €1.94 Billion | €1.51 Billion | €2.04 Billion |
SIEMENS HEALTH ADR/050 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes SIEMENS HEALTH ADR/050's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | €46.05 Billion | €46.68 Billion | €49.06 Billion |
| Total Current Assets | €14.44 Billion | €14.14 Billion | €13.38 Billion |
| Cash & Equivalents | — | — | — |
| Short-term Investments | €92.00 Million | €124.00 Million | €162.00 Million |
| Net Receivables | €4.41 Billion | €4.42 Billion | €4.22 Billion |
| Inventory | €4.14 Billion | €4.26 Billion | €3.97 Billion |
| Property, Plant & Equipment | — | — | — |
| Goodwill | €17.66 Billion | €18.12 Billion | €19.06 Billion |
| Total Liabilities | €27.81 Billion | €28.55 Billion | €29.20 Billion |
| Total Current Liabilities | €11.57 Billion | €13.44 Billion | €12.02 Billion |
| Long-term Debt | €0.00 | €10.00 Million | €15.00 Million |
| Net Debt | — | — | — |
| Total Stockholder Equity | €18.20 Billion | €18.08 Billion | €19.84 Billion |
| Retained Earnings | €2.15 Billion | €1.38 Billion | €894.00 Million |
SIEMENS HEALTH ADR/050 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how SIEMENS HEALTH ADR/050 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating Cash Flow | €2.83 Billion | €2.12 Billion | €2.50 Billion |
| Capital Expenditures | €696.00 Million | €838.00 Million | €852.00 Million |
| Free Cash Flow | €2.13 Billion | €1.28 Billion | €1.65 Billion |
| Investing Cash Flow | — | — | — |
| Financing Cash Flow | — | — | — |
| Dividends Paid | €1.06 Billion | €1.07 Billion | €955.00 Million |
| Stock-Based Compensation | — | — | — |
| Depreciation | €1.22 Billion | €1.56 Billion | €1.34 Billion |
| Change in Cash | €437.00 Million | €130.00 Million | €114.00 Million |
SIEMENS HEALTH ADR/050 Earnings History — EPS Actual vs. Analyst Estimates
Track SIEMENS HEALTH ADR/050's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jul 31, 2026 | — | — | — |
| May 07, 2026 | — | — | — |
| Feb 05, 2026 | — | — | — |
| Nov 05, 2025 | 0.52 | 0.43 | +20.93% |
| Jul 30, 2025 | 0.49 | 0.32 | +53.13% |
| May 07, 2025 | 0.47 | 0.00 | — |
| Feb 06, 2025 | 0.42 | 0.00 | — |
| Nov 06, 2024 | — | — | — |